Evidence map›Paper›PMID 29442269›Full record

ArticleMolecular and cellular biochemistry2018

Effects of carvacrol on human fibroblast (WS-1) and gastric adenocarcinoma (AGS) cells in vitro and on Wistar rats in vivo.

Ayse Günes-Bayir, Abdurrahim Kocyigit, Eray Metin Güler, Mehmet Gültekin Bilgin, İlyas Samet Ergün, Agnes Dadak

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
5.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Pharmaceuticals (Basel, Switzerland) · 2025
    Article
  6. Review
  7. Effect of carvacrol to induce autophagy and apoptosis and its interaction with Newcastle disease virus in the chicken embryo model.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2025
    Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Ayse Günes-BayirDepartment of Nutrition and Dietetics, Faculty of Health Sciences, Bezmialem Vakif University, Silahtarağa Caddesi No: 189, Eyüp, 34065, Istanbul, Turkey. agunes@bezmialem.edu.tr.
Abdurrahim KocyigitDepartment of Medical Biochemistry, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey.
Eray Metin GülerDepartment of Medical Biochemistry, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey.
Mehmet Gültekin BilginDepartment of Nutrition and Dietetics, Faculty of Health Sciences, Bezmialem Vakif University, Silahtarağa Caddesi No: 189, Eyüp, 34065, Istanbul, Turkey.
İlyas Samet ErgünDepartment of Pathology Laboratory, Vocational School for Health Services, Bezmialem Vakif University, Istanbul, Turkey.
Agnes DadakInstitute of Pharmacology, Department for Biomedical Sciences, University of Veterinary Medicine Vienna, Vienna, Austria.
Bezmiâlem Vakıf Üniversitesi · TRUniversity of Veterinary Medicine Vienna · AT

Funding

Bezmiâlem Vakif Üniversitesi 12.2014/3Bezmiâlem Vakif Üniversitesi 3.2016/23Bezmiâlem Vakif Üniversitesi 6.2016/3
6 · The paper itself

Abstract

Carvacrol is a natural phenolic compound found in essential oils of Lamiaceae species. In the present study, an attempt has been made to elucidate the mechanism behind the anti-cancer potential of carvacrol on human gastric adenocarcinomas (AGS) by comparing its effects on cancer cells AGS to those on normal human fibroblast (WS-1) cells, in vitro. Cytotoxicity, reactive oxygen species (ROS) generation, glutathione (GSH) levels, genotoxicity, and apoptotic effects of carvacrol (0-600 µM) were studied in both cell lines. Additionally, the effect of high dose carvacrol (100 mg/kg BW) on the oxidative status was investigated in vivo. For this purpose, carvacrol was administered orally to male Wistar rats over a period of 60 days. Rats were weighed regularly. At the end of the experiment, rats were euthanized. Blood and stomach tissues were collected for biochemical and pathological examinations. The in vitro results showed significant differences in cell viability of AGS compared to WS-1 cells exposed to carvacrol. Also the extent of ROS generation, GSH reduction and DNA damage differed significantly between the cell lines studied (P ≤ 0.001). The differences observed were statistically significant at all concentrations applied (P ≤ 0.001). The results found in AGS cells were mirrored in the pathohistological findings obtained from animals of the in vivo experimental group. Changes in body weight, and oxidative stress index for plasma and stomach tissues of animals in this group were found to differ statistically significant from those found in the control group of Wistar rats (P ≤ 0.001). The data obtained from our present study uncovered that carvacrol has the potential to cause toxic effects in both, AGS and WS-1 cells but more effectively in cancer cells than in normal cells. The carvacrol-mediated responses observed in the in vitro and in vivo experiments presented suggest a double-edged pro-oxidative effect. Via this mechanism carvacrol induced cytotoxicity, apoptosis, and DNA damage in a dose-dependent manner in both cancer and normal cells and these activities were higher in cancer cells than those of normal cells.

Indexed as

DNA DamageAdenocarcinomaAnimalsCell Line, TumorCymenesFibroblastsHumansMaleMonoterpenesOxidative StressRatsRats, WistarStomach NeoplasmscarvacrolCymenesMonoterpenesApoptosisCarvacrolHuman fibroblast cellsHuman gastric adenocarcinoma cellsOxidative stress statusPro-oxidant activity

Identifiers

PMID29442269
OpenAlexW2791847456

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.